Op-Eds
The U.S. must fix its innovation engine: the patent system
Adam Mossoff
March 8, 2022
US Economy 2022: Diversity And Inclusion For The Heartland
Paul R. Michel
March 6, 2022
Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them
Andrei Iancu, David Kappos, and Paul R. Michel
March 4, 2022
Big Tech is abusing the U.S. patent challenge system
Paul R. Michel
February 18, 2022
Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law
Adam Mossoff
February 15, 2022
The Supreme Court is partly to blame for the Covid-19 test kit shortage
Paul R. Michel
February 7, 2022
Can We Please Get Serious About Patents and Drug Pricing?
Barney Cassidy
January 6, 2022
World leaders should acknowledge that IP protections facilitate vaccine access
Andrei Iancu
December 24, 2021
Why does the FDA want to stop improving medicines via patent ‘areas of concern’?
Andrei Iancu
November 8, 2021
Time to Fight Back Against Big Tech’s IP Assault
Paul R. Michel
October 25, 2021